Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth.
For the last decade, new cancer-fighting drugs have been topping $5,000 a month. Only a few of these keep cancer in remission so long that they are, in effect, cures. For most people, the drugs may buy a few months or years. Insurers usually pay if Medicare pays. But some people have lifetime caps and more people are uninsured because of job layoffs in the recession. The nation's new health care law eliminates these lifetime limits for plans that were issued or renewed on Sept. 23 or later.
Job losses have led some people to stop taking Gleevec, a $4,500-a-month drug by Novartis AG that keeps certain leukemias and stomach cancers in remission. Three such cases were recently described in the New England Journal of Medicine, and all those patients suffered relapses.
There is not enough evidence to confirm that Tylenol causes autism but the pain medication should...
Ali Mokdad stands in the heart of Beirut. Cars and trucks and motorcycles rumble everywhere."If you...
At just 13 years old, Kevin Tang is establishing himself in the world of science and...
Nearly 80 people got sick in a norovirus outbreak on an Oceania Cruises ship.Among the 637...
